|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| ||||||||||||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) |
1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
Bluestein Sanfurd 2150 N. OCEAN BLVD., APT 4N BOCA RATON, FL 33431 |
X |
/s/ Sanfurd Bluestein | 06/24/2008 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | Dr. Bluestein indirectly owns these shares of common stock of the Issuer (the "Shares"), which are directly owned by the Bluestein Family Foundation, Inc. (the "Foundation"), a private foundation of which Dr. Bluestein is the Manager, and over which Dr. Bluestein shares voting and investment control pursuant to third party trading authorizations. Dr. Bluestein has elected to report the entire amount of the Foundation's interest in the securities of the issuer, pursuant to Instruction 4(b)(iv) of this Form. Dr. Bluestein directly beneficially owns 733,000 Shares. Additionally, Dr. Bluestein indirectly owns 137,000 Shares, which are directly owned by Oppenheimer & Co. Inc., custodian for Sanfurd G. Bluestein IRA, over which Dr. Bluestein has sole voting and investment control; |
(2) | (continued from Footnote 1) 175,000 Shares, which are directly owned by Bluestein Family Partnership, LP, a private foundation of which Dr. Bluestein is the Manager; 175,000 Shares, which are directly owned by Joel Bluestein, Dr. Bluestein's son; 10,800 Shares, which are directly owned by Doris Hasnas, Dr. Bluestein's sister; 55,000 Shares, which are directly owned by Jessica Ann Bishop Trust #2, for the benefit of Dr. Bluestein's granddaughter; and 60,000 Shares, which are directly owned by JR Trusts, LLC, which is wholly owned by Jessica Reisman Trust #1 and Jessica Reisman Trust #2, over which Dr. Bluestein has sole voting and investment control. |